Short Interest in CellaVision AB (publ) (OTCMKTS:CLVSF) Grows By 400.0%

CellaVision AB (publ) (OTCMKTS:CLVSF) was the target of a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 500 shares, a growth of 400.0% from the February 13th total of 100 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 5.0 days.

CellaVision AB (publ) Stock Performance

Shares of OTCMKTS:CLVSF remained flat at $19.28 on Wednesday. CellaVision AB has a one year low of $19.28 and a one year high of $19.91. The company’s fifty day simple moving average is $19.48 and its two-hundred day simple moving average is $22.88.

CellaVision AB (publ) Company Profile

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides CellaVision DM1200 and CellaVision DM9600, designs to automate and simplify the process of performing blood and body fluid differentials; CellaVision DC-1, an analyzer to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell; and DIFF-Line that automates and digitizes the process of analyzing peripheral blood smears.